A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature

Lignende værker

• Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors
  af: Oh, Felix, et al.
  Udgivet: (2020)
• Targeting EGFR and uPAR on human rhabdomyosarcoma, osteosarcoma, and ovarian adenocarcinoma with a bispecific ligand-directed toxin
  af: Oh, Felix, et al.
  Udgivet: (2018)
• Bispecific Targeting of EGFR and uPAR in a Mouse Model of Head and Neck Squamous Cell Carcinoma
  af: Waldron, Nate N., et al.
  Udgivet: (2012)
• Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
  af: Borgatti, Antonella, et al.
  Udgivet: (2017)
• Bioengineering a unique deimmunized bispecific targeted toxin that simultaneously recognizes human CD22 and CD19 receptors in a mouse model of B cell metastases
  af: Vallera, Daniel A., et al.
  Udgivet: (2010)